Dystonia Clinical Trials
Sutter Health participates in clinical trials related to Dystonia throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.
Title: DYSPORT for Injection AbobotulinumtoxinA Neurotoxin Clinical and Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD) (Tercica, Inc.)Opens in a new window 
Decscription: The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
Investigator: Matthew Arnold, MD
Eligibility: Patients with Cervical Dystonia/Spasmodic Torticollis.
Status: Active and open to enrollment
Location: Alta Bates Summit Medical Center
Contact: Jody Dosanjh 510-204-1610 Email: dosanjp@sutterhealth.org
Title: DYSPORT for Injection AbobotulinumtoxinA Neurotoxin Clinical and Health Economics Outcomes Registry in Cervical Dystonia (ANCHOR-CD)Opens in a new window
Decscription: The purpose of the protocol is to determine typical patient response to Dysport in the treatment of adult cervical dystonia (CD).
Investigator: Nicklesh Thakur, DO
Eligibility:
Status: Active and open to enrollment
Location: Sutter Neuroscience Institute
Contact: SH Neuroscience Group 916-454-6850
> See All Neurology Clinical Trials by Condition